United Therapeutics Corporation is a pharmaceutical company that develops and commercializes therapies for pulmonary arterial hypertension, a condition of high blood pressure in the arteries of the lungs. Its products include prostacyclin-based medicines delivered by infusion, inhalation and other routes, and it also pursues work in organ manufacturing and transplant technologies. The company is based in Silver Spring, Maryland, in the United States, and its medicines reach patients and clinicians in markets around the world.
United Therapeutics Corporation is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code U2TH34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #629 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
49/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average0.2%
From 52-week high-12.0%
MomentumWeak
42/100
Lagging most stocks on this exchange.
See the numbers →
3-month return1.7%
6-month return-12.0%
12-month, skipping last month5.9%
Stability (higher is calmer)Strong
86/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)23.4%
Worst drawdown, 1 year (smaller is calmer)-17.4%
LiquidityWeak
30/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.02M BRL
Zero-volume days83.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 113.63 – 155.07Daily closes, split-adjusted
Signals
50-day average129.33
200-day average134.91
Golden/death cross (60d)Death, 41 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.38
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
8 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
6 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
133.6
Bullish
EMA 10
133.6
Bullish
SMA 20
130.3
Bullish
EMA 20
131.7
Bullish
SMA 50
129.3
Bullish
EMA 50
130.8
Bullish
SMA 100
132.7
Bullish
EMA 100
132.0
Bullish
SMA 200
134.9
Bullish
EMA 200
130.4
Bullish
Oscillators (daily)
RSI (14)
92.56
Bearish
MACD (12, 26)
1.98
Bullish
Momentum (12)
6.49
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
83.33
Neutral
Pivot points (classic, last session)
S3
135.2
S2
135.2
S1
135.2
Pivot
135.2
R1
135.2
R2
135.2
R3
135.2
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
